140 related articles for article (PubMed ID: 37222130)
1. Cutaneous mastocytosis in 8 young dogs and review of literature.
Yang C; Bradley CW; Preziosi D; Mauldin EA
Vet Pathol; 2023 Nov; 60(6):849-856. PubMed ID: 37222130
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis in the skin in dogs: A multicentric case series.
Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
[TBL] [Abstract][Full Text] [Related]
3. Lokivetmab therapy for pruritus in a dog with cutaneous mastocytosis.
Meichner K; Kiupel M; Kasantikul T; Rakich P; Banovic F
Vet Dermatol; 2019 Feb; 30(1):73-e22. PubMed ID: 30479052
[TBL] [Abstract][Full Text] [Related]
4. Histologic grading of canine mast cell tumor: is 2 better than 3?
Sabattini S; Scarpa F; Berlato D; Bettini G
Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
[TBL] [Abstract][Full Text] [Related]
5. Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours.
Moore AS; Frimberger AE; Taylor D; Sullivan N
Vet Comp Oncol; 2020 Sep; 18(3):402-408. PubMed ID: 31916687
[TBL] [Abstract][Full Text] [Related]
6. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
[TBL] [Abstract][Full Text] [Related]
7. Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection.
Sledge DG; Webster J; Kiupel M
Vet J; 2016 Sep; 215():43-54. PubMed ID: 27372911
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Canine Mast Cell Tumor Mortality Risk Based on Clinical, Histologic, Immunohistochemical, and Molecular Features.
Horta RS; Lavalle GE; Monteiro LN; Souza MCC; Cassali GD; Araújo RB
Vet Pathol; 2018 Mar; 55(2):212-223. PubMed ID: 29338615
[TBL] [Abstract][Full Text] [Related]
9. Comparison of minichromosome maintenance protein 7, Ki67 and mitotic index in the prognosis of intermediate Patnaik grade cutaneous mast cell tumours in dogs.
Berlato D; Murphy S; Laberke S; Rasotto R
Vet Comp Oncol; 2018 Dec; 16(4):535-543. PubMed ID: 29989314
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and Prognosis of Canine Cutaneous Mast Cell Tumors.
Kiupel M; Camus M
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):819-836. PubMed ID: 31178200
[TBL] [Abstract][Full Text] [Related]
11. Canine cutaneous and subcutaneous mast cell tumours: a narrative review.
Bellamy E; Berlato D
J Small Anim Pract; 2022 Jul; 63(7):497-511. PubMed ID: 34671978
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
Aytemiz Danyer I; Gürel A
Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
[TBL] [Abstract][Full Text] [Related]
13. Histologically low-grade, yet biologically high-grade, canine cutaneous mast cell tumours: A systematic review and meta-analysis of individual participant data.
Bae S; Milovancev M; Bartels C; Irvin VL; Tuohy JL; Townsend KL; Leeper H
Vet Comp Oncol; 2020 Dec; 18(4):580-589. PubMed ID: 32103587
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum tryptase as a diagnostic oncological marker in canine versus human mast cell neoplasms.
De Vos S; Demeyere K; De Cock H; Devriendt N; Schwarzkopf I; Fortrie R; Roggeman T; Meyer E; De Spiegelaere W; de Rooster H
Res Vet Sci; 2022 Dec; 151():90-95. PubMed ID: 35872552
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2- and 3-category histologic grading systems for predicting the presence of metastasis at the time of initial evaluation in dogs with cutaneous mast cell tumors: 386 cases (2009-2014).
Stefanello D; Buracco P; Sabattini S; Finotello R; Giudice C; Grieco V; Iussich S; Tursi M; Scase T; Di Palma S; Bettini G; Ferrari R; Martano M; Gattino F; Marrington M; Mazzola M; Elisabetta Vasconi M; Annoni M; Marconato L
J Am Vet Med Assoc; 2015 Apr; 246(7):765-9. PubMed ID: 25794126
[TBL] [Abstract][Full Text] [Related]
16. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
[TBL] [Abstract][Full Text] [Related]
17. Features and prognostic impact of distant metastases in 45 dogs with de novo stage IV cutaneous mast cell tumours: A prospective study.
Pizzoni S; Sabattini S; Stefanello D; Dentini A; Ferrari R; Dacasto M; Giantin M; Laganga P; Amati M; Tortorella G; Marconato L
Vet Comp Oncol; 2018 Mar; 16(1):28-36. PubMed ID: 28233400
[TBL] [Abstract][Full Text] [Related]
18. c-KIT messenger RNA and protein expression and mutations in canine cutaneous mast cell tumors: correlations with post-surgical prognosis.
Giantin M; Vascellari M; Morello EM; Capello K; Vercelli A; Granato A; Lopparelli RM; Nassuato C; Carminato A; Martano M; Mutinelli F; Dacasto M
J Vet Diagn Invest; 2012 Jan; 24(1):116-26. PubMed ID: 22362941
[TBL] [Abstract][Full Text] [Related]
19. Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference.
Northrup NC; Howerth EW; Harmon BG; Brown CA; Carmicheal KP; Garcia AP; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Gieger TL
J Vet Diagn Invest; 2005 Nov; 17(6):561-4. PubMed ID: 16475514
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and prognostic value of c-kit and TP53 mutations in canine mast cell tumours.
Vozdova M; Kubickova S; Fictum P; Fröhlich J; Jelinek F; Rubes J
Vet J; 2019 May; 247():71-74. PubMed ID: 30971355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
